Where can I buy the Indian version of lorlatinib/lorlatinib?

Lorlatinib/Lorlatinib (Lorlatinib) is developed and produced by Pfizer. It is mainly used to treat ALK-positive non-small cell lung cancer (NSCLC). Due to its higher treatment cost, some patients may consider seeking other versions of lorlatinib, such as generic versions. Although India has strong production capabilities in generic drugs, there are currently no original or generic drugs of lorlatinib produced in India. Most of the counterfeit versions available on the market are produced in other countries, such as Laos and Bangladesh. The ingredients of these generic drugs are basically the same as those of the original drugs, and their therapeutic effects have been recognized by most patients.

Since India's regulatory system for generic drugs is relatively loose, some drugs may enter the market through different channels. However, the availability of generic versions of lorlatinib in India is relatively limited. At present, the original drug or generic drugs of lorlatinib have not been widely launched in the Indian market. If most patients want to purchase lorlatinib, they usually need to obtain it through international drug import channels or from other countries (such as Bangladesh and Laos). Although the quality of generic drugs in these countries is relatively reliable, patients still need to choose carefully and ensure that the drugs are from regular sources to avoid buying fake and inferior products.

In addition, with the global push for drug price transparency, more and more online drug platforms have begun to provide international procurement services for lorlatinib. Patients can contact regular suppliers through these platforms to learn about relevant purchase channels. Only drugs purchased through formal channels can ensure efficacy and safety.

In summary, although India currently does not produce original or generic drugs of lorlatinib, generic drugs in Bangladesh and Laos are still common alternatives. When choosing a purchasing channel, patients should carefully consider the quality and source of the drug, and give priority to formal channels.

Keyword tags: lorlatinib, lorlatinib, India, generic drugs, purchase, Bangladesh, Laos, drug import, drug quality

References:https://en.wikipedia.org/wiki/Lorlatinib